Tag Archives: NASDAQ:ONCS

Analysts’ Top Services Picks: OncoSec Medical (ONCS), Pareteum Corp (TEUM)

There’s a lot to be optimistic about in the Services sector as 2 analysts just weighed in on OncoSec Medical (ONCS – Research Report) and Pareteum Corp (TEUM – Research Report) with bullish sentiments. OncoSec Medical (ONCS) Maxim Group analyst

Maxim Group Maintains Their Buy Rating on OncoSec Medical (ONCS)

Maxim Group analyst Jason McCarthy maintained a Buy rating on OncoSec Medical (ONCS – Research Report) today and set a price target of $5. The company’s shares opened today at $0.59, close to its 52-week low of $0.42. McCarthy observed:

Analyst Explains Why They Downgraded Their Rating on OncoSec Medical (ONCS)

In a report released today, Ram Selvaraju from H.C. Wainwright downgraded OncoSec Medical (ONCS – Research Report) to Hold, with a price target of $1. The company’s shares closed yesterday at $0.87, close to its 52-week low of $0.68. Selvaraju

OncoSec Medical (ONCS) Gets a Buy Rating from Maxim Group

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on OncoSec Medical (ONCS – Research Report), with a price target of $5. The company’s shares opened today at $0.79, close to its 52-week low of

H.C. Wainwright Reiterates Their Buy Rating on OncoSec Medical (ONCS)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on OncoSec Medical (NASDAQ: ONCS) today and set a price target of $4. The company’s shares closed yesterday at $1.66. Selvaraju commented: “Our price target is derived from a market value

OncoSec Medical (ONCS) Gets a Buy Rating from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on OncoSec Medical (NASDAQ: ONCS), with a price target of $4. The company’s shares closed on Friday at $1.61. Selvaraju wrote: “Our price target is derived